- Research article
- Open Access
Derivation and validation of murine histologic alterations resembling asthma, with two proposed histologic grade parameters
© Wachtel et al; licensee BioMed Central Ltd. 2009
- Received: 20 January 2009
- Accepted: 30 October 2009
- Published: 30 October 2009
The objective was to define murine histologic alterations resembling asthma in a BALB/c OVA model and to suggest grading criteria. Identified were six salient histologic findings in lungs with putative allergic inflammation: 1) bronchoarterial space inflammation; 2) peri-venular inflammation; 3) inflammation about amuscular blood vessels; 4) inter-alveolar space inflammation, not about capillaries; 5) pleural inflammation; and 6) eosinophils within the inflammatory aggregates. An initial study comprised six groups of twelve mice each: 1) stressed, control; 2) stressed, sensitized; 3) stressed, challenged; 4) not physically stressed, control; 5) not physically stressed, sensitized; 6) not physically stressed, challenged. A second study comprised four experimental groups of twenty mice each: 1) stressed, control; 2) stressed, challenged; 3) not physically stressed, control; 4) not physically stressed, challenged. A third study evaluated two grading criteria, 1) the proportion of non-tracheal respiratory passages with inflammatory aggregates and 2) mitoses in the largest two non-tracheal respiratory passages, in five groups of five mice each, evaluated at different times after the last exposure.
The first study suggested the six histological findings might reliably indicate the presence of alterations resembling asthma: whereas 82.4% of mice with a complete response had detectable interleukin (IL)-5, only 3.8% of mice without one did; whereas 77.8% of mice with a complete response were challenged mice, only 6.7% of mice without complete responses were. The second study revealed that the six histological findings provided a definition that was 97.4% sensitive and 100% specific. The third study found that the odds of a bronchial passage's having inflammation declined 1) when mitoses were present (OR = 0.73, 0.60 - 0.90), and 2) with one day increased time (OR = 0.75, 0.65 - 0.86).
A definition of murine histologic alterations resembling asthma in the BALB/c OVA mouse was developed and validated. The definition will be of use in experiments involving this model to ensure that all mice said to have undergone an asthmatic attack did indeed reveal allergic pulmonary inflammation. Proposed grading criteria should be further evaluated with additional studies using physiologic measures of attack severity and increased airway resistance.
- Allergic Challenge
- Incomplete Response
- Ovum Mouse
- Stressed Mouse
- Histological Group
Asthma currently afflicts about 300,000,000 persons and was estimated in 2005 to have killed 255,000 . Although some have considered murine models to be inappropriate as means of understanding human asthma , most feel the mouse model is vital, especially with respect to the understanding of the early response to antigens and the mediators of allergic asthma [3, 4]. The BALB/c OVA mouse model is one of the most commonly used . Although a general understanding of the histological findings of the BALB/c OVA mouse has been generated by the publication of different studies , a systematic approach to the most important aberrations to garner a readily identifiable histological definition has not been performed. Such a definition would be of utility as a safeguard when performing studies using the BALB/c OVA mouse because it would ensure that all individual animals submitted for study experienced histologic changes resembling asthma. Moreover, such a definition would be of use because therapeutic manipulations that abolish the findings would then be designated as successfully obliterating the attack. Posited was a specific pattern of histological findings, derivable from generally accepted observations of BALB/c OVA mice. Six salient findings were identified in lung sections with putative allergic inflammation: 1) bronchoarterial space inflammation; 2) peri-venular inflammation; 3) inflammation about amuscular blood vessels; 4) inter-alveolar space inflammation, not about capillaries; 5) pleural inflammation; and 6) eosinophils within the inflammatory aggregates. An initial study comprised of six experimental groups of twelve mice each, randomly assigned: 1) stressed, control; 2) stressed, sensitized; 3) stressed, challenged; 4) not physically stressed, control; 5) not physically stressed, sensitized; 6) not physically stressed, challenged. A second study comprised of four experimental groups of twenty mice each, randomly assigned: 1) stressed, control; 2) stressed, challenged; 3) not physically stressed, control; 4) not physically stressed, challenged. A third study evaluated two grading criteria, 1) the proportion of non-tracheal respiratory passages with inflammatory aggregates and 2) the presence or absence of mitoses in the largest two non-tracheal respiratory passages, in five experimental groups of five mice each, assigned to different times after the last exposure.
Definition of murine histologic alterations resembling asthma
Studies to establish and validate the definition of murine histologic alterations resembling asthma
Of the 80 mice from the second study, two mice, both challenged and stressed, expired before the end of the swim stress; the pair was excluded from further assessment. A second table [see Additional file 2- Table S2] shows that the different experimental protocols differentiated mice with respect to the presence or absence of a complete response protocols (P < 0.05) and that they failed to do so with respect to hemorrhage (P > 0.05) and alveolar dilatation (P > 0.05). Stress did not affect the likelihood of a complete response; complete responses were seen in 18 of 38 (47.4%) stressed mice and 19 of 40 (47.5%) non-stressed mice (P > 0.05). By contrast, complete responses were seen in 37 of 38 (97.4%) challenged mice and 0 of 40 (0%) control mice (P < 0.05), yielding a sensitivity of 97.4% and a specificity of 100%.
Studies performed to propose potential grading parameters
A third table [see Additional file 3- Table S3] displays results of the study of the quantitative proliferation/hypertrophy markers that evaluated 64 mice from the second study set. Relationships of cells per 0.1 mm and mitoses with dilatation, hemorrhage, stress and one another were explainable by chance (P > 0.05 for each evaluation). The median number of cells per 0.1 mm of basement membrane was four fewer for allergic mice than control mice (P < 0.05); the difference, too small to use for evaluation of subgroups of challenged animals, was consistent with the presence of larger cells, perhaps via induction of goblet cell metaplasia. Mitoses were seen in 65.6% of allergic mice and 3.1% of controls (OR = 54.9, 7.3 - 2484.5, P < 0.05).
Histologic changes deemed important in the OVA BALB/c mouse model in previous studies were found in the current effort, but this study identified a set of six histological findings that the second study set showed was 97.4% sensitive and 100% specific for mice underwent an allergic challenge. Acute stress was evaluated by multiple comparisons and never found to be of importance in this model. Alveolar dilatation and hemorrhage, not being shown to be associated with allergic challenge, stress, detectable IL-4, detectable IL-5, epithelial cell concentration, or mitotic activity, likely resulted from bronchoalveolar lavage (BAL). Although the semi-quantitative grading system did not prove successful in the first study group, quantitative measures proved more promising: in the second study group, challenged mice, when compared with control mice, had a small but significant decrease in bronchial epithelial cells per 0.1 mm basement membrane and markedly increased odds of having mitoses in the largest non-tracheal respiratory passage. In the third study, time since exposure was associated with a decline in the proportion of inflamed non-tracheal respiratory passages, a decline that was increased by the presence of mitoses in the two largest non-tracheal respiratory passages. The latter finding allows one to posit as grading parameters the proportion of inflamed respiratory passages and mitotic activity.
Prior studies of the BALB/c OVA mouse asthma model that evaluated pulmonary histological changes in some cases restricted their interest to the trachea or main bronchus [7, 27, 28]. Collins  provided results of histologic evaluations of 15 mice, with photographs that appear to show a complete response for acutely sensitized mice and an incomplete response for chronically sensitized mice. Because immunization is known to in and of itself be responsible in humans and cats for an anaphylaxis, [29, 30] the findings suggest that any study comparing immunized and allergic mice carefully evaluate the histological findings in all animals to exclude those who experienced allergic pulmonary inflammation resulting from the immunization. Four sensitized animals in this study developed a complete histological response. The allergic response, if it occurred, occurred at an earlier stage is suggested by the absence of detectable IL-5 in three of the mice.
When histological findings are obliterated by therapy, the change of a histological response, and not the degree of the response, is documented. Soluble IL-15Rα  and rolipram  obliterate inflammation, extirpating, not simply diminishing, the response. Antigen pulsed dendritic cells alter the histological appearance by eliminating the eosinophils, which does not merely diminish the asthmatic attack, but actually reduces the airway responsiveness to methylcholine beneath that observed in control animals ; the latter paper is of note, as it identified as important interalveolar and subpleural inflammatory infiltrate. Desmet [23, 24] showed diminution to an apparent incomplete response after treatment with nuclear factor- κB (NF-κB) and activator protein-1 decoy oligodeoxyribonucleotides. Photographs in this paper show peri-bronchial inflammation, the reason for the designation, in this paper, of "bronchoarterial space." Inflammation is not uniformly distributed about the airways, but shows a marked predilection for the side adjacent to arteries and arterioles. For this reason, statements such as "peri-bronchial and peri-vascular" [22, 25] confuse unless the latter term references pulmonary veins. However, IL-4 and IL-13 were reported to induce airway responsiveness in the absence of inflammation .
de Siqueira  found wrinkling of the epithelium and dilatation of the alveolar spaces, which they demarcated as emphysematous to be of importance. Because their mice underwent BAL, it became of interest to see if the wrinkling and the alveolar dilatation might be unrelated to an asthmatic challenge. Some degree of bronchial epithelial wrinkling was seen in at least one airway in all mice; because quantifying the degree of wrinkling and the proportion of airways with wrinkling was difficult at best. This study concentrated on two relatively easily observed indications of lung injury not seen in every mouse--alveolar dilatation (denoted by these authors as emphysema) and hemorrhage. The results of the present study showed the latter two findings bore no relationship to stress, allergic challenge, IL-4, IL-5, the number of epithelial cells per 0.1 mm of basement membrane, or mitoses, meaning they likely reflected injury from BAL. Although such remodeling might be seen in mice that had not undergone BAL as a result of an allergic insult, the changes would be irrelevant to the determination of the presence or absence of histologic alterations resembling asthma after BAL; therefore we suggest studies of remodelling after BAL must take into account the potential for BAL-induced changes.
Brewer  included a grading system that evaluated the percentage of bronchioles involved. The promising results may have been in part due to its comparing mice that lacked an allergic/asthmatic response to mice that bore one; among all but the four mice strains who had both extremely low airway reactivity and inflammation, there appeared to be no relationship between the inflammatory scores and reactivity. The present study affirmed the diagnostic utility of the proportion of respiratory passages involved by inflammation. Pastva  devised a semi-quantitative inflammatory grading system that served as the basis of the one used in this study. We did not notice differences in cell height, which in the exercised/stressed group shown by their figure 1b appeared similar to that seen in another published study of an unexercised mouse group . Furthermore, it was unclear what the authors meant by degree of inflammation. Evaluation of the modified grading system showed no results that were inexplicable by chance, but did suggest the direction of the remaining grading studies. Because hematoxylin and eosin is not the best stain to evaluate mucin, any conclusion with respect to mucin is of limited value.
Different mouse strains and different allergic/asthma models yield different histological appearances [8, 10–12]. For each mouse strain, a histological definition of the murine histologic alterations resembling asthma should be derived and verified. The current findings apply only to the BALB/c OVA mouse model. Strain of mouse and antigen/model selection will influence the inflammatory response and persistence of airway responsiveness .
Varying the time between last exposure and sacrifice decreases the acute response with time [6, 31]. Molecular markers may also be of use; Duan [14, 15] evaluated the effectiveness of p38α mitogen-activated protein kinase anti-sense oligonucleotide and U0126, a specific MAPK/ERK kinase inhibitor on inflammation as outcomes to evaluate a scoring system . Concerning grading parameters, although the number of bronchial epithelial cells/mm2 was slightly lower, consistent with the notion that larger cells were replacing smaller cells [32, 33], the small size of the differences precludes their routine use. Image analysis is likewise time consuming, but does have the advantage of some objectivity. One study showed differences in the concentration of eosinophils  over time, as well as, with the use of immunohistochemistry, changes in smooth muscle thickness . When time after stress was used as a means to provide a graded level of mediator, the proportion of respiratory passages showing inflammation and the presence of mitoses proved important, suggesting the possibility of their utility in a histological grading system. The histological score might be a better guide for the severity of allergic pulmonary inflammation than analysis of BAL fluid or chemical analyses of whole tissue sample. Eisenbarth  assessed the importance of differing concentrations of lipopolysacharide on the asthmatic response. Photographs of hematoxylin and eosin stained sections showed no difference with respect to the dosage of lipopolysaccharide, notwithstanding marked changes in the laboratory findings. In the grading criteria proposed here, the proportion of inflamed respiratory passages and mitoses, are of interest because they lie in opposition to one another. One fault of prior grading systems is the assumption that all findings are additive.
The two different stresses deserve further comment. Psychostimulants such as amphetamine and cocaine can induce a withdrawal syndrome minimally obfuscated by somatic signs, being mostly a psychological/neurochemical stressor . Withdrawal from repeated amphetamine stimulation results in distress and depressive-like behaviors in rodent models [34, 35]. In humans, the relatively transient withdrawal" or "distress" syndrome is characterized by depression, including psychomotor alterations, dysphoria, anxiety, anhedonia and anergia . Post stimulants can also induce psychotic states in humans. In rats, repeated administration of psychomotor stimulants, such as amphetamine leads to behavioral sensitization and a progressive augmentation of behavioral responses to drug administrations, which persist even after long withdrawal periods [34, 36]. Although the forced swim test would seem to simply be a acute physical stressor, it is also a model of the mental stress of depression [37–39] during acute stress, being a widely used pharmacologic model for assessing antidepressant activity in the rodent laboratory [35, 39]. Researchers describe a "depressive" behavior as the floating response because the swimming behavior ceases and a state of despair or subjective helplessness is observed [36, 38]. Neither form of stress proved important in any overall way that could not have been explained by chance, supporting the utility of the definition in animals that had undergone stress and animals that had not undergone stress. Because two amphetamine-stressed control animals developed a complete response and had detectable IL-5, relationship of stress to the induction of an acute allergic response must be further explored. Future analyses of allergic asthma might wish to quantify differences in BAL fluid with respect to inflammatory mediators and extensively analyze the effects of changes in immunization protocols to assess differences between mice that are physically stressed and mice that only experience psychological stress.
In another report by our laboratory, an analysis of mean levels of IL-4, but not IL-5, were elevated among mice exposed to the forced swim test compared to control mice Thus, while control and non-allergic-challenged stressed mice did not differ in the proportion of mice with detectable IL-4 in BAL, the mean levels of IL-4 were elevated among stressed mice. Mice with histologic alterations resembling asthma responded to stress differently than did control mice, such that mean IL-4 levels did not differ between stressed and non-stressed allergic animals By contrast, although mean IL-5 levels were elevated among allergic challenged animals, stress actually reduced mean IL-5 levels in BAL among allergic mice
Limitations of this study include the absence of image analysis, special stains, gene expression analyses, and immunohistochemical studies, and lack of data on airway resistance. The definition and proposed grading system is limited to the BALB/c OVA mouse model. Similar studies should be undertaken for other mouse models before identifying a histologic alterations resembling asthma. There exists no reason a priori for levels of any specific inflammatory mediator in any specific mouse model to correlate with the degree of severity of an allergic challenge because inflammatory mediators may induce a response without a proportional histological response. The proposed grading system must be verified by a physiologic grading system that includes measures of air way resistance or pulmonary hyperresponsiveness. Despite these limitations, the value of the histological definition lies in the simplicity and speed with which the most commonly used murine model of allergic pulmonary inflammation can be confirmed. With practice, the identification of a response takes less than one minute and can be performed on animals that have little or no other measures of allergic pulmonary inflammation or asthma.
A definition of murine histologic changes resembling asthma has been developed and verified. We describe and validate histological features previously designated as being specific to allergic pulmonary inflammation and to the injury induced by BAL. Because the histological constellation is unaffected by the presence or absence of stress and was validated in the presence of BAL cytokine changes, it should find utility in studies that use the BALB/c OVA mouse model. An allergic pulmonary inflammation grading system was also proposed.
This work was approved by the Texas Tech University Animal Care and Use Committee prior to the start of work. For the initial study, 72 female BALB/c mice (6 to 8 weeks of age) were obtained from Charles Rivers Laboratories (Boston, MA); two mice were housed per bedded shoebox cage with a filter top. For the second study, 80 female BALB/c mice (8 weeks of age) were obtained from Jackson Laboratories (Bar Harbor, ME); two mice were housed per bedded shoebox cage with a filter top. Differences in the source of the animals related to purchasing arrangements of the animal care facility, but the animal strains were identical for all three study groups. For the third study, 25 female BALB/c mice (6 to 8 weeks of age) were obtained from Charles Rivers Laboratories (Boston, MA); five mice were housed per bedded shoebox cage with a filter top. Animals were maintained at 21-23°C with a 12:12 h light-dark cycle. Mice were provided an OVA free diet and water ad libitum. Animal protocols were approved by the Animal Care Committee of the Texas Tech University, which is accredited by AAALAC International. Animals were randomly assigned by cage to the different treatment and stress groups. The first study comprised six groups of twelve mice each, randomly assigned: 1) stressed, control; 2) stressed, sensitized; 3) stressed, challenged; 4) not stressed, control; 5) not stressed, sensitized; 6) not stressed, challenged. The second study comprised four groups of twenty mice each, randomly assigned: 1) stressed, control; 2) stressed, challenged (two of whom died); 3) not stressed, control; 4) not stressed, challenged. For the third study, challenged, not stressed mice were randomly assigned by cage to one of five time exposure treatments (0, 12, 24, 36, and 48 hours).
For the first study set, stress comprised intraperitoneal injections of amphetamine (d-amphetamine (AMP, Sigma-Aldrich, St. Louis, MO) 1 mg/kg, dissolved in saline less than one hour before injection), on days 21, 22, and 23; mice who did not experience stress were provided intraperitoneal injections of sterile saline. For the second study set, stress comprised a 20 minute forced swim in a glass cylindrical jar, 27 cm tall, and 12 cm diameter, filled 15 cm with water maintained at 28-30°C . Stress was induced on day 26 immediately prior to euthanization for the first two studies.
For the third study set, after the last exposure of aerosolized 1% OVA, mice were randomly assigned by cage to one of five time after exposure treatments (0, 12, 24, 36 and 48 h). For 0 and 12 h treatments, mice were exposed to aerosol OVA at 7:00 h and harvested at 7:20 h and 19:20 h respectively. For 24 and 36 h treatments, mice were exposed to aerosolized OVA at 7:30 h and harvested the next day at 7:50 h and 19:50 h respectively. For 48 h treatment mice were exposed to aerosol OVA at 8:00 h and harvested 48 h later at 8:20 h. The aerosol exposure and harvest times were allotted these times due to availability of equipment, although a stringent schedule was allotted to avoid variability from circadian effects
Immune activation was performed similarly to established allergy models [37, 41]. On days 7, 14, and 21 sensitized and challenged mice received 10 μg of OVA (crude grade IV; Sigma, St. Louis, MO) i.p. emulsified in 100 μL of aluminum hydroxide gel (Sigma) and suspended in 100 μL of PBS . Control mice received 200 μL of vehicle intra-peritoneally. Systemic levels of OVA-specific immunoglobulin (Ig)E were allowed to increase for 15 days after the fist sensitizing injection. On days 22, 23, 24, and 25, mice allocated to the challenged treatment group were exposed for 20 min to aerosolized OVA in PBS (1% w/v) generated with a nebulizer (Minimate Compressor PM, Precision Medical, Inc., North Hampton, PA) and mice in the control and sensitized treatment groups were exposed to aerosolized PBS for 20 min, a similar established method to previous studies , immediately before euthanization.
All mice chosen for the first two study sets were euthanized on day 26 using CO2 inhalation followed by thoracic decompression; mice chosen for the third study set were euthanized at time periods described above using using CO2 inhalation followed by thoracic compression. Immediately after euthanization, tracheas were exposed surgically and cannulated using an 18 g needle. Lungs were lavaged with 2 × 0.5 mL aliquots of ice cold PBS/2% fetal bovine serum (FBS). Supernatant was collected after centrifuging samples for 10 min at 1200 rpm and immediately frozen in a -70°C freezer. Multiple analyses were performed on the BAL fluid, blood, and serum, reported elsewhere (Sutherland, submitted); but the only measurements relevant to this effort were the IL-4 and IL-5 measurements performed BAL and IgE measurements performed on serum on the first study group when sufficient material was present. IL-4 and IL-5 levels were determined by by ELISA (Assay Designs, Ann Arbor MI), following manufacturer's guidelines, with sensitivity for IL-4 being 4.34 pg/ml and for IL-5 being 5 pg/ml. Plasma IgE concentrations were assayed at a 1:50 dilution by a commercially available ELISA kit (Bethyl Laboratories, Montgomery, TX) with a sensitivity of 3.9 ng/ml, according to the manufacturer's instructions.
Lungs were then surgically harvested and placed into 10% formalin for at least 5 days prior to paraffin embedding. Histologic analyses were performed on 4 μ thick parasagittal sections of whole lungs stained with hematoxylin and eosin. Totally embedded lungs of mice were evaluated for six changes deemed most important, as described in the results.. Second study set lungs were further examined for the presence or absence of alveolar dilatation and hemorrhage.
All mice from the first study with a complete response were selected for evaluation of a subjective inflammatory grading system. Pastva  had created a semi-quantitative system to evaluate the intensity of inflammation based on a series of subjective criteria, 1) bronchial inflammation; 2) vascular inflammation; 3) epithelial hyperplasia/hypertrophy; 4) goblet cells and mucin production; and 5) overall lung appearance. Initial attempts to distinguish overall bronchial from overall vascular inflammation were quite difficult, and Pastva  found neither a statistically significant criterion; the two criteria were fused into "bronchovascular inflammation." Although PAS staining was not performed, goblet cells were identified in all mice. Some form of hypertrophy/hyperplasia was also seen in virtually every mouse. For these reasons, each of the three categories, 1) bronchovascular inflammation, 2) epithelial hyperplasia/hypertrophy, and 3) goblet cell metaplasia/mucin production, was graded on a 1-4 scale, with 4 being the most severe and 1 being the least. Scores were multiplied by an overall severity score, graded from 1-4, and summed to yield an inflammation index. From the second study set were chosen 32 challenged mice with a complete histologic response and 32 control mice, none of whom had had a complete histologic response, for quantitative evaluation of two proliferation/hypertrophy indices: for each mouse the largest non-tracheal airway was evaluated at 200× for 1) the presence or absence of bronchial epithelial mitoses and 2) the number of epithelial cells counted over 0.1 mm of basement membrane in a flattened area. All mice in the third study set with a complete response were evaluated for two parameters: 1) the largest two non-tracheal airways were evaluated at 200× for the presence or absence of mitoses; 2) for all material on the slide, non-tracheal respiratory passages were evaluated at 100× for chronic inflammatory infiltrates and the number with and the number without inflammatory infiltrates were recorded.
Fisher's exact tests, two-tailed, evaluated contingency tables, with exact methods used to establish 95% confidence intervals (95% c.i.) for 2 × 2 tables. A Kruskal-Wallis tests, two-tailed, evaluated differences in medians. For univariate comparisons with a continuous outcome variable, simple linear regression analyses calculated point estimates and 95% c.i. of mean differences. For multivariate comparisons with a continuous outcome variable, log gamma regression calculated point estimates and 95% c.i. of mean ratios for continuous outcome variables. Binomial logistic regression analyses calculated adjusted odds ratios (OR) and 95% c.i. for multivariate analyses with dichotomous outcome variables and with analyses of dichotomous outcome variables with continuous predictor variables. Multinomial logit regression analyses calculated relative risks (RR) and 95% c.i. for categorical outcome variables other than dichotomous. Null hypotheses were rejected when P < 0.05.
The authors thank Lindsey Hulbert for care of experimental animals and the Howard Hughes Memorial Institute undergraduate research program and the Departments of Internal Medicine, Pathology, and Animal and Food Sciences for financial support during this work.
- WHO: Asthma. Fact Sheet N° 307. Geneva, Switzerland. 2008, World Health Organization, last accessed 16 October 2009, [http://www.who.int/mediacentre/factsheets/fs307/en/index.html]Google Scholar
- Persson CG: Con: mice are not a good model of human airway disease. Am J Respir Crit Care Med. 2002, 166: 6-7. 10.1164/rccm.2204001. discussion 8View ArticlePubMedGoogle Scholar
- Epstein MM: Do mouse models of allergic asthma mimic clinical disease?. Int Arch Allergy Immunol. 2004, 133: 84-100. 10.1159/000076131.View ArticlePubMedGoogle Scholar
- Gelfand EW: Pro: mice are a good model of human airway disease. Am J Respir Crit Care Med. 2002, 166: 5-6. 10.1164/rccm.2204023. discussion 7-8View ArticlePubMedGoogle Scholar
- Kurucz I, Szelenyi I: Current animal models of bronchial asthma. Curr Pharm Des. 2006, 12: 3175-94. 10.2174/138161206778194169.View ArticlePubMedGoogle Scholar
- Blyth DI, Pedrick MS, Savage TJ, Bright H, Beesley JE, Sanjar S: Induction, duration, and resolution of airway goblet cell hyperplasia in a murine model of atopic asthma: effect of concurrent infection with respiratory syncytial virus and response to dexamethasone. Am J Respir Cell Mol Biol. 1998, 19: 38-54.View ArticlePubMedGoogle Scholar
- Temelkovski J, Hogan SP, Shepherd DP, Foster PS, Kumar RK: An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax. 1998, 53: 849-56.PubMed CentralView ArticlePubMedGoogle Scholar
- Brewer JP, Kisselgof AB, Martin TR: Genetic variability in pulmonary physiological, cellular, and antibody responses to antigen in mice. Am J Respir Crit Care Med. 1999, 160: 1150-6.View ArticlePubMedGoogle Scholar
- Herz U, Braun A, Ruckert R, Renz H: Various immunological phenotypes are associated with increased airway responsiveness. Clin Exp Allergy. 1998, 28: 625-34. 10.1046/j.1365-2222.1998.00280.x.View ArticlePubMedGoogle Scholar
- Ichinose T, Takano H, Miyabara Y, Yanagisawa R, Sagai M: Murine strain differences in allergic airway inflammation and immunoglobulin production by a combination of antigen and diesel exhaust particles. Toxicology. 1997, 122: 183-92. 10.1016/S0300-483X(97)00096-6.View ArticlePubMedGoogle Scholar
- Shinagawa K, Kojima M: Mouse model of airway remodeling: strain differences. Am J Respir Crit Care Med. 2003, 168: 959-67. 10.1164/rccm.200210-1188OC.View ArticlePubMedGoogle Scholar
- Collins RA, Sly PD, Turner DJ, Herbert C, Kumar RK: Site of inflammation influences site of hyperresponsiveness in experimental asthma. Respir Physiol Neurobiol. 2003, 139: 51-61. 10.1016/j.resp.2003.09.003.View ArticlePubMedGoogle Scholar
- de Siqueira AL, Russo M, Steil AA, Facincone S, Mariano M, Jancar S: A new murine model of pulmonary eosinophilic hypersensitivity: contribution to experimental asthma. J Allergy Clin Immunol. 1997, 100: 383-8. 10.1016/S0091-6749(97)70253-7.View ArticlePubMedGoogle Scholar
- Duan W, Chan JH, McKay K, Crosby JR, Choo HH, Leung BP, Karras JG, Wong WS: Inhaled p38alpha mitogen-activated protein kinase antisense oligonucleotide attenuates asthma in mice. Am J Respir Crit Care Med. 2005, 171: 571-8. 10.1164/rccm.200408-1006OC.View ArticlePubMedGoogle Scholar
- Duan W, Chan JH, Wong CH, Leung BP, Wong WS: Anti-inflammatory effects of mitogen-activated protein kinase kinase inhibitor U0126 in an asthma mouse model. J Immunol. 2004, 172: 7053-9.View ArticlePubMedGoogle Scholar
- Myou S, Leff AR, Myo S, Boetticher E, Tong J, Meliton AY, Liu J, Munoz NM, Zhu X: Blockade of inflammation and airway hyperresponsiveness in immune-sensitized mice by dominant-negative phosphoinositide 3-kinase-TAT. J Exp Med. 2003, 198: 1573-82. 10.1084/jem.20030298.PubMed CentralView ArticlePubMedGoogle Scholar
- Pastva A, Estell K, Schoeb TR, Atkinson TP, Schwiebert LM: Aerobic exercise attenuates airway inflammatory responses in a mouse model of atopic asthma. J Immunol. 2004, 172: 4520-6.PubMed CentralView ArticlePubMedGoogle Scholar
- Sakai K, Yokoyama A, Kohno N, Hamada H, Hiwada K: Prolonged antigen exposure ameliorates airway inflammation but not remodeling in a mouse model of bronchial asthma. Int Arch Allergy Immunol. 2001, 126: 126-34. 10.1159/000049503.View ArticlePubMedGoogle Scholar
- Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, Bottomly K: Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med. 2002, 196: 1645-51. 10.1084/jem.20021340.PubMed CentralView ArticlePubMedGoogle Scholar
- Ruckert R, Brandt K, Braun A, Hoymann HG, Herz U, Budagian V, Durkop H, Renz H, Bulfone-Paus S: Blocking IL-15 prevents the induction of allergen-specific T cells and allergic inflammation in vivo. J Immunol. 2005, 174: 5507-15.View ArticlePubMedGoogle Scholar
- Kanehiro A, Ikemura T, Makela MJ, Lahn M, Joetham A, Dakhama A, Gelfand EW: Inhibition of phosphodiesterase 4 attenuates airway hyperresponsiveness and airway inflammation in a model of secondary allergen challenge. Am J Respir Crit Care Med. 2001, 163: 173-84.View ArticlePubMedGoogle Scholar
- Graffi SJ, Dekan G, Stingl G, Epstein MM: Systemic administration of antigen-pulsed dendritic cells induces experimental allergic asthma in mice upon aerosol antigen rechallenge. Clin Immunol. 2002, 103: 176-84. 10.1006/clim.2002.5190.View ArticlePubMedGoogle Scholar
- Desmet C, Gosset P, Henry E, Garze V, Faisca P, Vos N, Jaspar F, Melotte D, Lambrecht B, Desmecht D, et al.: Treatment of experimental asthma by decoy-mediated local inhibition of activator protein-1. Am J Respir Crit Care Med. 2005, 172: 671-8. 10.1164/rccm.200410-1431OC.View ArticlePubMedGoogle Scholar
- Desmet C, Gosset P, Pajak B, Cataldo D, Bentires-Alj M, Lekeux P, Bureau F: Selective blockade of NF-kappa B activity in airway immune cells inhibits the effector phase of experimental asthma. J Immunol. 2004, 173: 5766-75.View ArticlePubMedGoogle Scholar
- Eum SY, Haile S, Lefort J, Huerre M, Vargaftig BB: Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin 5-dependent bronchial hyperresponsiveness. Proc Natl Acad Sci USA. 1995, 92: 12290-4. 10.1073/pnas.92.26.12290.PubMed CentralView ArticlePubMedGoogle Scholar
- Venkayya R, Lam M, Willkom M, Grunig G, Corry DB, Erle DJ: The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. Am J Respir Cell Mol Biol. 2002, 26: 202-8.View ArticlePubMedGoogle Scholar
- Foster PS, Ming Y, Matthei KI, Young IG, Temelkovski J, Kumar RK: Dissociation of inflammatory and epithelial responses in a murine model of chronic asthma. Lab Invest. 2000, 80: 655-62.View ArticlePubMedGoogle Scholar
- Kumar RK, Herbert C, Yang M, Koskinen AM, McKenzie AN, Foster PS: Role of interleukin-13 in eosinophil accumulation and airway remodelling in a mouse model of chronic asthma. Clin Exp Allergy. 2002, 32: 1104-11. 10.1046/j.1365-2222.2002.01420.x.View ArticlePubMedGoogle Scholar
- Erlewyn-Lajeunesse M, Bonhoeffer J, Ruggeberg JU, Heath PT: Anaphylaxis as an adverse event following immunisation. J Clin Pathol. 2007, 60: 737-9. 10.1136/jcp.2006.037457.PubMed CentralView ArticlePubMedGoogle Scholar
- Moore GE, DeSantis-Kerr AC, Guptill LF, Glickman NW, Lewis HB, Glickman LT: Adverse events after vaccine administration in cats: 2,560 cases (2002-2005). J Am Vet Med Assoc. 2007, 231: 94-100. 10.2460/javma.231.1.94.View ArticlePubMedGoogle Scholar
- Tanaka H, Masuda T, Tokuoka S, Takahashi Y, Komai M, Nagao K, Nagai H: Time course study on the development of allergen-induced airway remodeling in mice: the effect of allergen avoidance on established airway remodeling. Inflamm Res. 2002, 51: 307-16. 10.1007/PL00000309.View ArticlePubMedGoogle Scholar
- Reader JR, Tepper JS, Schelegle ES, Aldrich MC, Putney LF, Pfeiffer JW, Hyde DM: Pathogenesis of mucous cell metaplasia in a murine asthma model. Am J Pathol. 2003, 162: 2069-78.PubMed CentralView ArticlePubMedGoogle Scholar
- Tormanen KR, Uller L, Persson CG, Erjefalt JS: Allergen exposure of mouse airways evokes remodeling of both bronchi and large pulmonary vessels. Am J Respir Crit Care Med. 2005, 171: 19-25. 10.1164/rccm.200406-698OC.View ArticlePubMedGoogle Scholar
- Barr AM, Markou A: Psychostimulant withdrawal as an inducing condition in animal models of depression. Neurosci Biobehav Rev. 2005, 29: 675-706. 10.1016/j.neubiorev.2005.03.012.View ArticlePubMedGoogle Scholar
- Cryan JF, Hoyer D, Markou A: Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents. Biol Psychiatry. 2003, 54: 49-58. 10.1016/S0006-3223(02)01730-4.View ArticlePubMedGoogle Scholar
- Russig H, Pezze MA, Nanz-Bahr NI, Pryce CR, Feldon J, Murphy CA: Amphetamine withdrawal does not produce a depressive-like state in rats as measured by three behavioral tests. Behav Pharmacol. 2003, 14: 1-18.View ArticlePubMedGoogle Scholar
- Arai I, Tsuyuki Y, Shiomoto H, Satoh M, Otomo S: Decreased body temperature dependent appearance of behavioral despair in the forced swimming test in mice. Pharmacol Res. 2000, 42: 171-6. 10.1006/phrs.2000.0672.View ArticlePubMedGoogle Scholar
- Deak T, Bellamy C, D'Agostino LG, Rosanoff M, McElderry NK, Bordner KA: Behavioral responses during the forced swim test are not affected by anti-inflammatory agents or acute illness induced by lipopolysaccharide. Behav Brain Res. 2005, 160: 125-34. 10.1016/j.bbr.2004.11.024.View ArticlePubMedGoogle Scholar
- Dunn AJ, Swiergiel AH: Effects of interleukin-1 and endotoxin in the forced swim and tail suspension tests in mice. Pharmacol Biochem Behav. 2005, 81: 688-93. 10.1016/j.pbb.2005.04.019.PubMed CentralView ArticlePubMedGoogle Scholar
- Sutherland MA, Shome GP, Hulbert LE, Krebs M, Wachtel M, McGlone JJ: Acute stress affects the physiology and behavior of allergic mice. Physiology & Behavior. 2009, 98: 281-7. 10.1016/j.physbeh.2009.06.003.View ArticleGoogle Scholar
- Chu HW, Honour JM, Rawlinson CA, Harbeck RJ, Martin RJ: Effects of respiratory Mycoplasma pneumoniae infection on allergen-induced bronchial hyperresponsiveness and lung inflammation in mice. Infect Immun. 2003, 71: 1520-6. 10.1128/IAI.71.3.1520-1526.2003.PubMed CentralView ArticlePubMedGoogle Scholar
- Blyth DI, Wharton TF, Pedrick MS, Savage TJ, Sanjar S: Airway subepithelial fibrosis in a murine model of atopic asthma: suppression by dexamethasone or anti-interleukin-5 antibody. Am J Respir Cell Mol Biol. 2000, 23: 241-6.View ArticlePubMedGoogle Scholar
- Costa-Pinto FA, Basso AS, Britto LR, Malucelli BE, Russo M: Avoidance behavior and neural correlates of allergen exposure in a murine model of asthma. Brain Behav Immun. 2005, 19: 52-60. 10.1016/j.bbi.2004.02.005.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.